No Data
AEye (LIDR.US) will release its Earnings Reports after market close on February 20.
$AEye (LIDR.US) will release its Earnings Reports after the market closes on February 20; investors please pay attention. How were the previous performances? $AEye (LIDR.US) had revenue of $0.104 million and a Net income of -$-8.706 million with an EPS of -$1.01 for Q3 2024. In Q4 2023, revenue was $0.069 million with a Net income of -$-27.782 million and an EPS of -$4.44. The accounting standards used for the above data are US_GAAP. Futubull reminds: 1. There is no strict division of accounting years for listed companies in Hong Kong and the United States.
AEYE Health in Partnership With Topcon Healthcare, Inc, Announces Exceptional Usability and Clinical Efficacy for Autonomous Diabetic Retinopathy Screening
＜Today's individual materials＞ Aeye Inc, HOUSEI, Mitsubishi Research Institute, A-One, ETC (Announced on the 5th)
▽ Aeye Inc <4388.T> has set a stock buyback limit of 350,000 shares (5.15% of the total shares issued, excluding treasury stock) and a buyback amount of 250 million yen. ▽ HOUSEI <5035.T> has revised upward its consolidated earnings forecast for the fiscal year ending December 2024. ▽ Mitsubishi Research Institute <3636.T> anticipates a significant decrease in profits for the consolidated financial results of the first quarter of the fiscal year ending September 2025 (October-December 2024). ▽ A-One <6156.T> has revised downward its standalone earnings forecast for the cumulative second quarter of the fiscal year ending June 2025 (July-December 2024) and for the full year. ▽ SBI
Press Release: AEye to Report Fourth Quarter 2024 Financial Results on Thursday, February 20
AEye to Report Fourth Quarter 2024 Financial Results on Thursday, February 20
AEye to Participate in A.G.P.'s Virtual Technology Conference
